Everus Construction vs GEO
ECG and GEO side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ECG and GEO compare
Everus Construction and GEO are about the same size, with market caps of $4.2B and $4.3B.
On earnings, Everus Construction is cheaper: it trades at 14.7× trailing earnings, against 15.4× for GEO.
Everus Construction grew revenue faster over the last twelve months (33.5% versus 15.3% for GEO).
GEO keeps more of each dollar of sales as profit, with a net margin of 10.3% compared with 6.2% at Everus Construction.
Everus Construction scores higher on the StockData Score (17 against 10 for GEO), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ECG | GEO |
|---|---|---|
| Size and price | ||
| Market cap | $4.2B | $4.3B |
| Share price | $82.92 | $32.66 |
| Change, 1 year | −9.5% | 124% |
| Change, 5 years | – | 290% |
| Beta (5Y) | 1.59 | 0.68 |
| Employees | 10K | 18K |
| StockData Score | ||
| Total score | 17 (better) | 10 |
| Valuation score | 3 (better) | 0 |
| Growth score | 5 (better) | 4 |
| Performance score | 5 (better) | 4 |
| Health score | 4 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 14.7× (better) | 15.4× |
| P/S | 0.9× (better) | 1.5× |
| P/B | 4.9× | 2.8× (better) |
| EV/EBITDA | 11.9× (better) | 12.8× |
| P/FCF | 17.8× (better) | 163× |
| PEG | 0.85 (better) | 0.97 |
| FCF yield | 5.6% (better) | 0.62% |
| Fair value | $87.96 | $20.45 |
| Margin of safety | 5.7% (better) | −59.7% |
| Growth | ||
| Revenue growth (TTM) | 33.5% (better) | 15.3% |
| Revenue growth, 5Y average | – | 2.3% |
| Net income growth (TTM) | 59.9% | 222% (better) |
| EPS growth (TTM) | 60.1% | 226% (better) |
| EPS growth, 5Y average | – | 14.1% |
| Profitability | ||
| Gross margin | 13.6% | – |
| Operating margin | 8.2% | 11.2% (better) |
| Net margin | 6.2% | 10.3% (better) |
| FCF margin | 5.1% (better) | 0.94% |
| Return on equity | 40.3% (better) | 20.1% |
| Return on invested capital | 30.0% (better) | 7.6% |
| Financial health | ||
| Debt / equity | 0.66 (better) | 1.02 |
| Net debt / EBITDA | 0.79 (better) | 3.30 |
| Interest coverage | 18.7× (better) | 2.1× |
| Current ratio | 1.53 | 1.65 (better) |
| Altman Z-score | 4.21 (better) | 2.41 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Buyback yield | – | 4.1% |
| Shareholder yield | 0.00% | 4.1% (better) |
| Ownership | ||
| Held by institutions | 85.0% | 95.9% |
| Held by insiders | 0.57% | 4.1% |
| Insider net buying, 12 months | −$283K (better) | −$1.1M |
| Short interest, % of float | 4.1% | 8.8% |
Go deeper
- ECG stock overview
- ECG income statement
- ECG valuation and score
- GEO stock overview
- GEO income statement
- GEO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.